United States (US) Transdermal Scopolamine Patch Market (2025-2031) | Segmentation, Industry, Trends, Analysis, Competitive Landscape, Value, Share, Forecast, Outlook, Size & Revenue, Growth, Companies

Name: United States (US) Transdermal Scopolamine Patch Market (2025-2031) | Segmentation & Industry
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (1mg, 1.5mg), By Application (Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor, Others) And Competitive Landscape

Product Code: ETC9978343	Publication Date: Sep 2024	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

United States (US) Transdermal Scopolamine Patch Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The United States continues to rely on imports of transdermal scopolamine patches, with top exporting countries in 2024 being Israel, Belgium, Japan, Sweden, and Denmark. The Herfindahl-Hirschman Index (HHI) for these shipments saw a significant decrease from very low to low concentration from 2023 to 2024. The compound annual growth rate (CAGR) for the period 2020-2024 was -21.67%, with a steep decline in growth rate from 2023 to 2024 at -59.13%. This data suggests a shift in the dynamics of transdermal scopolamine patch imports into the US market.

United States (US) Transdermal Scopolamine Patch Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

United States (US) Transdermal Scopolamine Patch Market Outlook
Market Size of United States (US) Transdermal Scopolamine Patch Market, 2024
Forecast of United States (US) Transdermal Scopolamine Patch Market, 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Revenues & Volume for the Period 2021- 2031
United States (US) Transdermal Scopolamine Patch Market Trend Evolution
United States (US) Transdermal Scopolamine Patch Market Drivers and Challenges
United States (US) Transdermal Scopolamine Patch Price Trends
United States (US) Transdermal Scopolamine Patch Porter's Five Forces
United States (US) Transdermal Scopolamine Patch Industry Life Cycle
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By 1mg for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By 1.5mg for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Motion Sickness for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Nausea/Vomiting for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Parkinsonian Tremor for the Period 2021- 2031
Historical Data and Forecast of United States (US) Transdermal Scopolamine Patch Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Transdermal Scopolamine Patch Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Application
United States (US) Transdermal Scopolamine Patch Top Companies Market Share
United States (US) Transdermal Scopolamine Patch Competitive Benchmarking By Technical and Operational Parameters
United States (US) Transdermal Scopolamine Patch Company Profiles
United States (US) Transdermal Scopolamine Patch Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Transdermal Scopolamine Patch Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Transdermal Scopolamine Patch Market - Industry Life Cycle

3.4 United States (US) Transdermal Scopolamine Patch Market - Porter's Five Forces

3.5 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Transdermal Scopolamine Patch Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of motion sickness and postoperative nausea and vomiting

4.2.2 Growing demand for non-invasive drug delivery methods

4.2.3 Rising adoption of transdermal patches for convenient and continuous drug delivery

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for transdermal scopolamine patches

4.3.2 Potential side effects and skin irritations associated with transdermal patch usage

4.3.3 Competition from alternative forms of antiemetic medications

5 United States (US) Transdermal Scopolamine Patch Market Trends

6 United States (US) Transdermal Scopolamine Patch Market, By Types

6.1 United States (US) Transdermal Scopolamine Patch Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F

6.1.4 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F

6.2 United States (US) Transdermal Scopolamine Patch Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F

6.2.3 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F

6.2.4 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F

6.2.5 United States (US) Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Transdermal Scopolamine Patch Market Import-Export Trade Statistics

7.1 United States (US) Transdermal Scopolamine Patch Market Export to Major Countries

7.2 United States (US) Transdermal Scopolamine Patch Market Imports from Major Countries

8 United States (US) Transdermal Scopolamine Patch Market Key Performance Indicators

8.1 Patient compliance rate with transdermal scopolamine patch therapy

8.2 Number of clinical trials evaluating the efficacy and safety of transdermal scopolamine patches

8.3 Adoption rate of transdermal patches in the overall antiemetic market

9 United States (US) Transdermal Scopolamine Patch Market - Opportunity Assessment

9.1 United States (US) Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Transdermal Scopolamine Patch Market - Competitive Landscape

10.1 United States (US) Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024

10.2 United States (US) Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Transdermal Scopolamine Patch Market

Eritrea Transdermal Scopolamine Patch Market

Estonia Transdermal Scopolamine Patch Market

Ethiopia Transdermal Scopolamine Patch Market

Fiji Transdermal Scopolamine Patch Market

Finland Transdermal Scopolamine Patch Market

Global Transdermal Scopolamine Patch Market

Middle East Transdermal Scopolamine Patch Market

North America Transdermal Scopolamine Patch Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here